Evidence map›Paper›PMID 32322889›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Outbreaks of Adenovirus-associated Respiratory Illness on 5 College Campuses in the United States, 2018-2019.

Stephanie A Kujawski, Xiaoyan Lu, Eileen Schneider, David Blythe, Sameh Boktor, Janice Farrehi, Thomas Haupt, David McBride, Emily Stephens, Senthilkumar K Sakthivel and 12 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 1 country.

Stephanie A KujawskiDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Xiaoyan LuDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eileen SchneiderDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
David BlytheMaryland Department of Health Prevention and Health Promotion, Baltimore, Maryland, USA.
Sameh BoktorPennsylvania Department of Health, Harrisburg, Pennsylvania, USA.
Janice FarrehiUniversity Health Service, University of Michigan, Ann Arbor, Michigan, USA.
Thomas HauptWisconsin Department of Health Services, Madison, Wisconsin, USA.
David McBrideUniversity Health Center, University of Maryland, College Park, Maryland, USA.
Emily StephensVirginia Department of Health, Richmond, Virginia, USA.
Senthilkumar K SakthivelDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Brian BachausMaryland Department of Health Prevention and Health Promotion, Baltimore, Maryland, USA.
Kirsten WallerPennsylvania Department of Health, Harrisburg, Pennsylvania, USA.
Laura BaumanWashtenaw County Health Department, Ypsilanti, Michigan, USA.
Agustina MarconiUniversity Health Services, University of Wisconsin, Madison, Wisconsin, USA.
Rebecca LewisHenrico County Health Department, Virginia Department of Health, Richmond, Virginia, USA.
Lisa DettingerPennsylvania Department of Health, Harrisburg, Pennsylvania, USA.
Robert ErnstUniversity Health Service, University of Michigan, Ann Arbor, Michigan, USA.
William KinseyUniversity Health Services, University of Wisconsin, Madison, Wisconsin, USA.
Stephen LindstromDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Susan I GerberDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
John T WatsonDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Holly M BiggsDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
National Center for Immunization and Respiratory Diseases · USCenters for Disease Control and Prevention · USPennsylvania Department of Health · USMaryland Department of Health · USUniversity of Michigan–Ann Arbor · USVirginia Department of Health · USWisconsin Department of Health Services · USUniversity of Maryland, College Park · USUniversity of Wisconsin–Madison · USWashtenaw Community College · US

Funding

NCEZID CDC HHS U50 CK000375
6 · The paper itself

Abstract

backgroundHuman adenoviruses (HAdVs) are commonly associated with acute respiratory illness. HAdV outbreaks are well documented in congregate military training settings, but less is known about outbreaks on college campuses. During fall 2018 and spring 2019, 5 United States (US) colleges reported increases in HAdV-associated respiratory illness. Investigations were performed to better understand HAdV epidemiology in this setting.

methodsA case was defined as a student at one of the 5 colleges, with acute respiratory illness and laboratory-confirmed HAdV infection during October 2018-December 2018 or March-May 2019. Available respiratory specimens were typed by HAdV type-specific real-time polymerase chain reaction assays, and for a subset, whole genome sequencing was performed. We reviewed available medical records and cases were invited to complete a questionnaire, which included questions on symptom presentation, social history, and absenteeism.

resultsWe identified 168 HAdV cases. Median age was 19 (range, 17-22) years and 102 cases (61%) were male. Eleven cases were hospitalized, 10 with pneumonia; 2 cases died. Among questionnaire respondents, 80% (75/94) missed ≥ 1 day of class because of their illness. Among those with a type identified (79%), HAdV types 4 and 7 were equally detected, with frequency of each varying by site. Genome types 4a1 and 7d were identified, respectively, by whole genome sequence analysis.

conclusionsHAdV respiratory illness was associated with substantial morbidity and missed class time among young, generally healthy adults on 5 US college campuses. HAdVs should be considered a cause of respiratory illness outbreaks in congregate settings such as college campuses.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanRespiratory Tract InfectionsAdenoviridaeAdultDisease OutbreaksHumansMalePhylogenyUnited StatesYoung Adultadenoviruscollegesoutbreakrespiratory illness

Identifiers

PMID32322889
PMCPMC8315123
OpenAlexW3019276206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.